Ovarian Hyperstimulation Syndrome Prevention

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 17, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

July 30, 2025

Conditions
Ovarian Hyper Stimulation Syndrome (OHSS)
Interventions
DRUG

Antagonist protocol for IVF

antagonist protocol with triggering by Decapeptyl

DRUG

Modified Agonist protocol for IVF with additive treatments as HCQ

giving additive drugs to agonist protocolas HCQ

Trial Locations (2)

12345

RECRUITING

Aljazeerah hospital, Giza

Unknown

RECRUITING

Algazeerah, Giza

All Listed Sponsors
lead

Aljazeera Hospital

OTHER